challenges for mrna lnp formulation development and manufacturing
Published 1 year ago • 236 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
1:49
what are the challenges associated with in vitro transcription when manufacturing mrna?
-
6:31
the unique challenges of lipid nanoparticle development and manufacturing
-
2:06
what are some of the unique challenges associated with mrna compared with other biologics?
-
2:06
what are some of the challenges developing and manufacturing bi- and multi-specific antibodies?
-
4:42
mrna - a new option for vaccines and therapeutics
-
1:45
enabling mrna delivery: how to solve lnp formulation challenges
-
46:15
west webinar: efficient delivery of sirna with lipid nanoparticles dr. villamagna
-
59:43
mrna digital week. analytical methods for a well-characterized mrna drug substance
-
39:44
application of microfluidic mixing for generating limit size nanoparticles
-
1:15
technologies addressing stability & delivery for mrna therapies/vaccines
-
28:24
formulating nanomedicines: current challenges and solutions
-
36:16
overcoming key challenges in vaccine development
-
7:28
lipid nanoparticle (lnp) production for mrna-based vaccines
-
2:02
what are the challenges to bring mrna therapies/mrna-based drugs to market?
-
58:58
clinical and commercial manufacturing of mrna therapeutics: opportunities and challenges
-
28:21
scale-up and manufacturing of self-amplifying rna-lnps for a covid-19 vaccine
-
1:00:07
process & analytical insights for gmp manufacturing of mrna-lipid nanoparticles
-
19:44
session 2: mrna lnp scale up for gmp vaccine production - dr. jason coleman
-
6:16
process development challenges in mrna therapeutics
-
55:20
gen webinar: accelerating mrna-lnp formulation screening for genomic drug discovery and development
-
4:01
regulatory challenges for cell-based therapies
-
6:37
tackling mrna manufacturing challenges (tides tv with nate spangler, phd)